Study explains "obesity paradox" in heart treatment
16th Nov 2006, 08:10 GMT
CHICAGO (Reuters) - Heavier patients with clogged heart arteries have lower death rates in the short term than their leaner counterparts because they get more aggressive treatment, a study said on Wednesday.
Study explains "obesity paradox" in heart treatment related news:
- Simple steps can speed heart attack care: study (Reuters) — Yahoo! Health: Health News
- Simple steps can speed heart attack care: study — Reuters: Health
- Rethinking Post-Heart-Attack Treatment — WSJ.com: US Business
- Neurogen's obesity drug in phase 1 trial — United Press International - Health Business
- Late angioplasty after heart attack no better than drug therapy — EurekAlert! - Breaking News
- Neurogen Announces Phase I Clinical Trial For Proprietary Obesity Drug — Health News from Medical News Today
- Vioxx successor poses heart risk in study — Boston Globe -- Business News
- Neurogen commences human testing of obesity drug — Pharmaceutical Business Review Latest News
- Study Casts Doubt on Stent Use — WSJ.com: What's News US
- Angioplasty 25 hours after heart attack no good, says new study — The Indian Express
Latest news from Reuters: Health:
- Blow to chest can be fatal in child athletes: study
- Two Canada professors win right to toke up at work
- Diabetes drug may cut heart risks: study
- Most U.S. women in the dark about HPV: survey
- Red meat linked to some breast cancers: study
- Weight-loss surgery safety varies drastically: study
- Flu shot linked to tiny rise in risk for ailment
- Human natural painkiller beats morphine: research
- Radioactive iodine linked to thyroid disease
- Children showing hardening of arteries: study